29 related articles for article (PubMed ID: 1196767)
1. COVID-19 vaccine platforms: Delivering on a promise?
Verdecia M; Kokai-Kun JF; Kibbey M; Acharya S; Venema J; Atouf F
Hum Vaccin Immunother; 2021 Sep; 17(9):2873-2893. PubMed ID: 34033528
[TBL] [Abstract][Full Text] [Related]
2. From empiricism to rational design: a personal perspective of the evolution of vaccine development.
De Gregorio E; Rappuoli R
Nat Rev Immunol; 2014 Jul; 14(7):505-14. PubMed ID: 24925139
[TBL] [Abstract][Full Text] [Related]
3. A clinical trial with Alice/R-75 strain, live attenuated serum inhibitor-resistant intranasal bivalent influenza A/B vaccine.
Spencer MJ; Cherry JD; Powell KR; Sumaya CV
Med Microbiol Immunol; 1979 Mar; 167(1):1-9. PubMed ID: 375050
[TBL] [Abstract][Full Text] [Related]
4. Trivalent live attenuated intranasal influenza vaccine administered during the 2003-2004 influenza type A (H3N2) outbreak provided immediate, direct, and indirect protection in children.
Piedra PA; Gaglani MJ; Kozinetz CA; Herschler GB; Fewlass C; Harvey D; Zimmerman N; Glezen WP
Pediatrics; 2007 Sep; 120(3):e553-64. PubMed ID: 17698577
[TBL] [Abstract][Full Text] [Related]
5. Use of an inhibitor-resistant live attenuated influenza vaccine in normal and asthmatic adults.
Warshauer DM; Minor TE; Inhorn SL; Reed CE; Dick EC
Dev Biol Stand; 1976; 33():184-90. PubMed ID: 782967
[TBL] [Abstract][Full Text] [Related]
6. The efficacy of live attenuated, cold-adapted, trivalent, intranasal influenzavirus vaccine in children.
Belshe RB; Mendelman PM; Treanor J; King J; Gruber WC; Piedra P; Bernstein DI; Hayden FG; Kotloff K; Zangwill K; Iacuzio D; Wolff M
N Engl J Med; 1998 May; 338(20):1405-12. PubMed ID: 9580647
[TBL] [Abstract][Full Text] [Related]
7. Clinical trials with intranasally administered WRL 105 strain live influenza vaccine in volunteers.
Freestone DS
Dev Biol Stand; 1976; 33():207-12. PubMed ID: 782971
[TBL] [Abstract][Full Text] [Related]
8. Shedding and immunogenicity of live attenuated influenza vaccine virus in subjects 5-49 years of age.
Block SL; Yogev R; Hayden FG; Ambrose CS; Zeng W; Walker RE
Vaccine; 2008 Sep; 26(38):4940-6. PubMed ID: 18662737
[TBL] [Abstract][Full Text] [Related]
9. Live attenuated influenza virus vaccine trial in children.
Hall CB; Douglas G; Fralonardo SA
Pediatrics; 1975 Dec; 56(6):991-8. PubMed ID: 1196767
[TBL] [Abstract][Full Text] [Related]
10. Safety, immunogenicity and efficacy of intranasal, live attenuated influenza vaccine.
Belshe R; Lee MS; Walker RE; Stoddard J; Mendelman PM
Expert Rev Vaccines; 2004 Dec; 3(6):643-54. PubMed ID: 15606348
[TBL] [Abstract][Full Text] [Related]
11. Current status of live attenuated influenza virus vaccine in the US.
Belshe RB
Virus Res; 2004 Jul; 103(1-2):177-85. PubMed ID: 15163507
[TBL] [Abstract][Full Text] [Related]
12. Live attenuated influenza vaccine in children.
Ambrose CS; Walker RE; Connor EM
Semin Pediatr Infect Dis; 2006 Oct; 17(4):206-12. PubMed ID: 17055372
[TBL] [Abstract][Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
